[Diagnostic and pathogenetic implications of the site specificity of antibody proteases in multiple sclerosis]
- PMID: 20540348
[Diagnostic and pathogenetic implications of the site specificity of antibody proteases in multiple sclerosis]
Abstract
Disseminated sclerosis is currently regarded as a CNS autoimmune disease. One of the mechanisms behind this pathology is antibody (AB) formation. In this context, recent data on AB with proteolytic activity are of importance because they participate in selective proteolysis of myelin proteins in patients with disseminated sclerosis. This paper focuses on AB-proteases associated with disseminated sclerosis and site-specificity of antibody-mediated proteolysis of myelin basic protein. Protocol of serodiagnostic algorithm to be used in clinical practice is described.
Similar articles
-
Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis.J Immunol. 2008 Jan 15;180(2):1258-67. doi: 10.4049/jimmunol.180.2.1258. J Immunol. 2008. PMID: 18178866
-
Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen.Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):281-6. doi: 10.1073/pnas.0509849103. Epub 2005 Dec 30. Proc Natl Acad Sci U S A. 2006. PMID: 16387849 Free PMC article.
-
Catalytic activity of autoantibodies toward myelin basic protein correlates with the scores on the multiple sclerosis expanded disability status scale.Immunol Lett. 2006 Feb 28;103(1):45-50. doi: 10.1016/j.imlet.2005.10.006. Epub 2005 Nov 4. Immunol Lett. 2006. PMID: 16297986
-
Specificity of autoantibodies to epitopes of myelin proteins in multiple sclerosis.J Neurol Sci. 2003 Jan 15;206(1):7-16. doi: 10.1016/s0022-510x(02)00349-0. J Neurol Sci. 2003. PMID: 12480078 Review.
-
[Mechanisms of the development of neurological signs in multiple sclerosis].Neurol Neurochir Pol. 1989 Jan;23(1):46-51. Neurol Neurochir Pol. 1989. PMID: 2479877 Review. Polish. No abstract available.
Cited by
-
Design Rationale and Development Approach for Pegfilgrastim as a Long-Acting Granulocyte Colony-Stimulating Factor.BioDrugs. 2015 Jun;29(3):185-98. doi: 10.1007/s40259-015-0127-4. BioDrugs. 2015. PMID: 25998211 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical